Order Article Reprints

Zhu M, Cloney-Clark S, Feng S-l, Parekh A, Gorinson D, Silva D, Skonieczny P, Wilson A, Kalkeri R, Woo W, et al. A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection. Microorganisms. 2023; 11(7):1789. https://doi.org/10.3390/microorganisms11071789

Zhu, Mingzhu, Shane Cloney-Clark, Sheau-line Feng, Anand Parekh, Drew Gorinson, David Silva, Paul Skonieczny, Adjele Wilson, Raj Kalkeri, Wayne Woo, and et al. 2023. "A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection" Microorganisms 11, no. 7: 1789. https://doi.org/10.3390/microorganisms11071789

Zhu, M., Cloney-Clark, S., Feng, S.-l., Parekh, A., Gorinson, D., Silva, D., Skonieczny, P., Wilson, A., Kalkeri, R., Woo, W., Cai, M. R., Fries, L., Glenn, G., & Plested, J. S. (2023). A Severe Acute Respiratory Syndrome Coronavirus 2 Anti-Spike Immunoglobulin G Assay: A Robust Method for Evaluation of Vaccine Immunogenicity Using an Established Correlate of Protection. Microorganisms, 11(7), 1789. https://doi.org/10.3390/microorganisms11071789